Basf (OTCMKTS:BASFY – Get Free Report) was upgraded by equities research analysts at Berenberg Bank to a “strong-buy” rating in a research report issued to clients and investors on Friday, Zacks.com reports.
A number of other analysts have also recently weighed in on the stock. Redburn Atlantic upgraded shares of Basf from a “neutral” rating to a “buy” rating in a research note on Tuesday, April 9th. BNP Paribas reiterated an “underperform” rating on shares of Basf in a research note on Monday, April 15th. Three research analysts have rated the stock with a sell rating, one has assigned a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.
Check Out Our Latest Stock Report on Basf
Basf Trading Down 1.6 %
Basf (OTCMKTS:BASFY – Get Free Report) last posted its earnings results on Thursday, April 25th. The basic materials company reported $0.46 earnings per share for the quarter. The business had revenue of $19.06 billion during the quarter. Basf had a return on equity of 5.85% and a net margin of 0.07%. On average, equities analysts forecast that Basf will post 0.87 EPS for the current fiscal year.
About Basf
BASF SE operates as a chemical company worldwide. It operates through six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The Chemicals segment provides petrochemicals and intermediates. The Materials segment offers advanced materials and their precursors for applications and systems comprising isocyanates, polyamides, and inorganic basic products, as well as specialties for plastics and plastics processing industries.
See Also
- Five stocks we like better than Basf
- Consumer Staples Stocks, Explained
- Snowflake Stock Rebounds, Flies Higher on AI Spending
- What Are Dividend Contenders? Investing in Dividend Contenders
- Complete Solaria, Senti, and POET: 3 High Volume Penny Stocks
- The How and Why of Investing in Gold Stocks
- Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
Receive News & Ratings for Basf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basf and related companies with MarketBeat.com's FREE daily email newsletter.